Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas

International Journal of Cancer

Volumn 110, Issue 2, 2004, Pages 177-182

  Kitago, Minoru ^a   Ueda, Masakazu ^a   Aiura, Koichi ^a   Suzuki, Keiichi ^a   Hoshimoto, Sojun ^a   Takahashi, Shin ^a   Mukai, Makio ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Heterogeneity; Intraductal papillary mucinous tumors; Microdissection; Non RI SSCP; Postoperative survival rate

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL TYPE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MICRODISSECTION; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PANCREAS TUMOR; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POINT MUTATION;

EID: 2342544035     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20084     Document Type: Article

References (31)

1. Ohhashi K, Murakimi Y, Mayuyama M, Takekoshi T, Ohta H, Ohhashi I. Four cases of mucous secreting pancreatic cancer (Japanese). Prog Dig Endosc 1982;20:348-51.
2. Morohoshi T, Kanda M, Asanuma K, Kloppel G. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 1989;64:1329-35.
3. Obara T, Saitoh Y, Maguchi H, Ura H, Yokota K, Okamura K, Namiki M. Papillary adenoma of the pancreas with excessive mucin secretion. Pancreas 1992;7:114-7.
4. Yamaguchi K, Ogawa Y, Chijiiwa K, Tanaka M. Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg 1996;171:427-31.
5. Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, Pellegata NS, Ranzani GN, Rickaert F, Kloppel G. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994;425:357-67.
6. Loftus EV, Olivares-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarr MG, DiMagno EP. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome and nomenclature. Gastroenterology 1996;110:1909-18.
7. Azar C, Van de Stadt J, Rickaert F, Deviere J, Delhaye M, Baize M, Kloppel G, Gelin M, Cremer M. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39:457-64.
8. Rivera JA, Fernandez-del Castillo C, Pins M, Compton CC, Lewandrowski KB, Rattner DW, Warshaw AD. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms: a single malignant clinicopathological entity. Ann Surg 1997;225:637-46.
9. Kloppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. World Health Organization international histological classification of tumours: histological typing of tumours of the exocrine pancreas, 2nd ed. Berlin: Springer-Verlag, 1996.
10. Almoguera C, Shibata D, Forrester K, Martin H, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
11. Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos HL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma. Nucleic Acids Res 1988;16:7773-82.
12. Grunewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, Janssen JWG, Bartram CR. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43:1037-41.
13. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S. Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 1989;80:622-6.
14. Nagata Y, Abe M, Motojima K, Nakayama E, Shiku H. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res 1990;81:135-40.
15. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993;217:138-43.
16. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-60.
17. Satoh K, Shimosegawa T, Moriizumi S, Koizumi M, Toyota T. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 1996;12:362-8.
18. Z'graggen K, Rivera JA, Compton CC, Pins M, Werner J, Castillo CF, Rattner DW, Lewandrowski KB, Rustgi AK, Warshaw AL. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997;226:491-500.
19. Lyons J, Janssen JWG, Bartram C, Layton M, Mufti GJ. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 1988;71:1707-12.
20. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, Kato Y. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
21. Tamagawa E, Ueda M, Takahashi S, Sugano K, Uematsu S, Mukai M, Ogata Y, Kitajima M. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997;3:2143-9.
22. Luttges J, Schilehe B, Menke MAOH, Vogel Ilka, Henne-Bruns D, Kloppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999;85:1703-10.
23. Levi S, Urbano-Ispizura A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
24. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990;5:1037-43.
25. Tada M, Omata M, Ohto M. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases. Cancer 1991;67:634-7.
26. Yanagisawa A, Kato Y, Ohtake K, Kitagawa T, Ohashi K, Hori M, Takagi K, Sugano H. c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 1991;82:1057-60.
27. Lemoine NR, Jain S, Hughes CH, Staddon SL, Maillet B, Hall PA, Kloppel G. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992;102:230-6.
28. Satoh K, Sawai T, Shimosegawa T, Koizumi M, Yamazaki T, Mochizuki F, Toyota T. The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasm of the pancreas. Int J Pancreat 1993;14:135-43.
29. Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Iwafuchi M, Yamano M, Kijima H, Saito T. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma. Jpn J Cancer Res 1999;90:841-8.
30. Fujii H, Inagaki M, Kasai S, Miyokawa N, Tokusashi Y, Gabrielson E, Hruban RH. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997;151:1447-54.
31. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997;57:2140-3.